221 related articles for article (PubMed ID: 759882)
1. Reduction in size of a pituitary tumor by bromocriptine therapy.
McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
[No Abstract] [Full Text] [Related]
2. [A case of Forbes-Albright syndrome treated with CB-154: has the tumor really disappeared? (author's transl)].
Kobayashi S; Shimura T; Nakazawa S
No Shinkei Geka; 1980 May; 8(5):463-7. PubMed ID: 7383261
[No Abstract] [Full Text] [Related]
3. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
[TBL] [Abstract][Full Text] [Related]
4. [Radiological control of prolactin adenomas treated with bromocriptine].
Metzger J; Gardeur D; Pehuet M; Houlbert D
Ann Med Interne (Paris); 1982; 133(1):59-60. PubMed ID: 7065592
[No Abstract] [Full Text] [Related]
5. [Bromocriptine for prolactin-secreting macroadenomas of the pituitary].
Landman L; Spindel A; Tal Y; Bar-Meir A; Sharf M; Dickstein G
Harefuah; 1987 Oct; 113(7-8):156-9. PubMed ID: 3428740
[No Abstract] [Full Text] [Related]
6. Pituitary adenomas. An update on their management with an emphasis on the role of bromocriptine.
Barrow DL; Tindall GT
J Clin Neuroophthalmol; 1983 Dec; 3(4):229-37. PubMed ID: 6232287
[TBL] [Abstract][Full Text] [Related]
7. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.
Nissim M; Ambrosi B; Bernasconi V; Giannattasio G; Giovanelli MA; Bassetti M; Vaccari U; Moriondo P; Spada A; Travaglini P; Faglia G
J Endocrinol Invest; 1982; 5(6):409-15. PubMed ID: 7169515
[No Abstract] [Full Text] [Related]
9. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
Tindall GT; Kovacs K; Horvath E; Thorner MO
J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167
[No Abstract] [Full Text] [Related]
10. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Goodman LA; Chang RJ
Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
[TBL] [Abstract][Full Text] [Related]
11. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
Esiri MM; Bevan JS; Burke CW; Adams CB
J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
[TBL] [Abstract][Full Text] [Related]
12. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
Passannanti G; Cardone A; Marafioti F; Alvino N
Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
[No Abstract] [Full Text] [Related]
13. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
Schettini G; Lombardi G; Merola B; Miletto P; Fariello C; Cirillo S; Fusco R; Lancranjan I
J Endocrinol Invest; 1988 Jan; 11(1):47-51. PubMed ID: 3361075
[TBL] [Abstract][Full Text] [Related]
15. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
[TBL] [Abstract][Full Text] [Related]
16. Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. Case report.
Alhajje A; Lambert M; Crabbé J
J Neurosurg; 1985 Aug; 63(2):288-92. PubMed ID: 4020451
[TBL] [Abstract][Full Text] [Related]
17. [Prolactin adenoma with ophthalmological manifestations. Treatment with bromocriptine].
Saraux H; Offret H; Brasnu C; Charpentier G
Bull Soc Ophtalmol Fr; 1980; 80(6-7):489-93. PubMed ID: 7408092
[No Abstract] [Full Text] [Related]
18. Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
Abs R; Parizel PM; Beckers A
J Endocrinol Invest; 1991 Feb; 14(2):135-8. PubMed ID: 1905737
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine treatment of prolactinomas.
McGregor AM; Hall K; Scanlon MF; Hall R
N Engl J Med; 1979 Jun; 300(24):1392. PubMed ID: 440369
[No Abstract] [Full Text] [Related]
20. Bromocriptine treatment of prolactinomas.
von Werder K; Eversmann T; Fahlbusch R; Rjosk HK
N Engl J Med; 1979 Jun; 300(24):1391-2. PubMed ID: 440368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
